Neurointervention.  2018 Sep;13(2):138-143. 10.5469/neuroint.2018.00990.

Endovascular Treatment of Idiopathic Intracranial Hypertension with Stenting of the Transverse Sinus Stenosis

  • 1Department of Neuroendovascular Therapy Center, Aichi Medical University, Nagakute, Japan.
  • 2Department of Neurosurgery and Endovascular Therapy, Osaka Medical College, Takatsuki, Japan.
  • 3Department of Neurosurgery, Ohnishi Neurosurgical Hospital, Akashi, Japan.


For many years, the pathophysiology of idiopathic intracranial hypertension (IIH) was interpreted as "secondary intracranial hypertension," and IIH was considered to be caused by brain edema due to obstructive sleep apnea. Another theory proposed cerebrospinal fluid (CSF) absorption impairment due to excessive medication with vitamin A derivatives. Other reports pointed out the importance of obesity, which may cause an impairment of intracranial venous drainage due to elevated right atrial pressure. Patients with medically refractory IIH have traditionally undergone a CSF diversion. Venous outlet impairment on IIH has recently been reported as a causative or contributory cause, and thus focused venoplasty of the stenotic sinus with a stent has emerged as a new treatment strategy. We report the cases of two patients who presented with headache and papilledema with IIH. They successfully underwent stent placement at the stenosis of the transverse sinus and experienced complete resolution of symptoms.


Idiopathic intracranial hypertension; Transvers sinus; Stenting
Full Text Links
  • NI
export Copy
  • Twitter
  • Facebook
Similar articles
Copyright © 2021 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: